CLU and Alzheimer disease: Clusterin, one of the complement cascade inhibitors, can bind to the receptor on brain endothelial cells and reduce the expression of inflammatory genes in an AD mouse model.129 Exercise may also influence the permeability of the BBB,130 thus reducing the infiltration of activated peripheral immune cells.